Get started
Author

Wanrong Zheng

Integrative analysis of a novel signature incorporating metabolism and stemness-related genes for risk stratification and assessing clinical outcomes and therapeutic responses in lung adenocarcinoma
2025 · Wanrong Zheng, Chuchu Zhou, et al. · BMC Cancer · 8
PDF
CDK4 as a Prognostic Marker of Hepatocellular Carcinoma and CDK4 Inhibitors as Potential Therapeutics
2024 · Fobao Lai, Yingbing Fang, et al. · Current Medicinal Chemistry · 7
iDILI-MT: identifying drug-induced liver injury compounds with a multi-head Transformer
2025 · Wanrong Zheng, Fobao Lai · PeerJ Computer Science · 2
PDF
Pan-cancer analysis of disulfidptosis with potential implications in prognosis, immune microenvironment, and drug resistance in human cancer
2024 · Fobao Lai, Wanrong Zheng, et al. · Aging · 2
Multi-Targeted Anti-Tumor Effects of Huaier: A Comprehensive Review of Molecular Mechanisms and Clinical Applications
2026 · Wanrong Zheng, Fobao Lai · International Journal of Pharmacology
PDF
Comprehensive pan-cancer analysis of CDCA8: implications for prognosis and therapeutic targeting
2026 · Wanrong Zheng, Weibin Qiu, et al. · Current Science
PDF
Potentiation of paclitaxel-induced apoptosis in a non-small cell lung cancer model using the traditional Chinese drug huaier: Network pharmacology analysis, experimental verification, and clinical impact
2025 · Wanrong Zheng, Fobao Lai · International Journal of Clinical Pharmacology and Therapeutics
PDF
Cell Division Cycle-Associated Protein 8 in Pan-Cancer: A Comprehensive Prognostic and Immune Infiltration Investigation
2023 · Wanrong Zheng, Chengqian Zhong, et al. · Research Square
PDF
Works count: 8
Citation count: 18
H-index: 2
I10-index:
Year
Topic
Type